Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Diagnostic Utility of Musculoskeletal Ultrasound in Early Postoperative Evaluation of Posttraumatic Repaired Hand Tendons.

NCT07238517 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-07-01
Last updated
2025-11-20

Condition(s) studied

Ultrasound EvaluationHand Tendon Injury

Investigational drug(s) / intervention(s)

MSK US

MSK US: Focus on early postoperative (first 6-12 weeks) assessment after post-traumatic tendon repair. Utilization of high-frequency dynamic ultrasound rather than static imaging or delayed MRI. Standardized scanning protocol and blinded interpretation to ensure diagnostic validity. Designed to evaluate the diagnostic utility of MSK-US compared with conventional clinical follow-up methods.

Study summary

To evaluate the role of musculoskeletal ultrasound in the early postoperative period following hand tendon repair. By assessing its diagnostic accuracy and clinical utility, the study seeks to determine whether routine MSK-US surveillance can contribute to earlier detection of complications, guide timely management decisions, and ultimately improve functional outcomes in patients undergoing hand tendon surgery.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: adults with primary hand tendon repair and able to return for US follow-up. \- Exclusion Criteria: Patients with collagen disease, congenital hand deformities, bone fractures, revision/staged repairs, active infection/poor wound access, or can't attend follow-up. \-

Primary outcome measure(s)

  • Diagnostic accuracy of musculoskeletal ultrasound (MSK-US) for detecting clinically significant postoperative complications — Up to 12 weeks after surgical repair
    The accuracy of musculoskeletal ultrasound (MSK-US) in identifying clinically significant postoperative complications following surgical repair of posttraumatic hand tendons. Complications include rerupture requiring reintervention, deep infection, symptomatic adhesion requiring surgical release, and large seroma or hematoma requiring drainage or evacuation. Diagnostic accuracy will be determined by comparing MSK-US findings to a composite clinical reference standard consisting of surgical findings, clinical assessment, and microbiological/imaging confirmation. Accuracy measures will include sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratios.

Trial sites (1)

FacilityCityRegionStatus
Assiut University Asyut Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07238517 on ClinicalTrials.gov ↗ ← All trials in Egypt